# OnCo record evera (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/evera/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "evera", "NCT05306340" ;
  schema:name "evERA"@en ;
  schema:description "In evERA, pairing an oral SERD with everolimus after CDK4/6 failure delayed progression by more than three months, and by four and a half months in ESR1-mutant tumours."@en ;
  schema:url <https://onco.cc/trials/evera/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05306340> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2022-08-03" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/hr-positive-metastatic-post-cdk46/> ;
  onco:technologies <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:targets <https://onco.cc/targets/estrogen-receptor/> ;
  onco:drugs <https://onco.cc/drugs/giredestrant/>, <https://onco.cc/drugs/everolimus/> ;
  onco:companies <https://onco.cc/companies/roche-genentech/> .